Effect of trihexyphenidyl, a non-selective antimuscarinic drug, on decarboxylation of l-dopa in hemi-Parkinson rats

By Izurieta-Sanchez P.   Sarre S.   Ebinger G.   Michotte Y.  

European Journal of Pharmacology, Vol. 353, Iss. 1, 1998-07 ,pp. : 33-42

Elsevier

Access to resources Recommend Favorite

Levodopa biotransformation in hemi-Parkinson rats: effect of dopamine receptor agonists and antagonists

By Sarre S.   Ebinger G.   Michotte Y.  

European Journal of Pharmacology, Vol. 296, Iss. 3, 1996-02 ,pp. : 247-260

Elsevier

Access to resources Recommend Favorite

Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens

By Mathe J.M.   Nomikos G.G.   Hildebrand B.E.   Hertel P.   Svensson T.H.  

European Journal of Pharmacology, Vol. 309, Iss. 1, 1996-08 ,pp. : 1-11

Elsevier

Access to resources Recommend Favorite

Receptor Heteromers in Parkinson’s Disease and L-DOPA-Induced Dyskinesia

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 8, 2013-12 ,pp. : 1101-1113

Bentham Science Publishers

Access to resources Recommend Favorite

Catalponol enhances dopamine biosynthesis and protects against l-DOPA-induced cytotoxicity in PC12 cells

By Huang Hai-Shan  

Journal of Asian Natural Products Research, Vol. 11, Iss. 10, 2009-10 ,pp. : 867-875

Taylor & Francis Ltd

Access to resources Recommend Favorite